STS/ACC TVT Registry Study Identifies Hospital Variation in TAVR Care

There are "substantial variations" in the quality of TAVR care delivered at the site level in the U.S., with about 11% of sites providing below-average care, according to a study published May 5 in Circulation.

In a retrospective cohort study, Nimesh D. Desai, MD, PhD, et al., looked at data from the STS/ACC TVT Registry to determine if site-level disparity in TAVR outcomes exists in the U.S. The researchers evaluated a cohort of 52,561 TAVR patients between Jan. 1, 2015, and Dec. 31, 2017, and used a novel ranked composite performance measure that considered two main factors: mortality and severe complications. After one year, the rank order of the complications was adjusted based on the correlation between the variable and the study's overall health outcomes. The risk-adjusted outcomes were determined with a 95% probability interval. The researchers found four periprocedural complications to include in the composite risk model: life-threatening or disabling bleeding; stroke; moderate or severe peri-valvular regurgitation; and stage III acute kidney injury.

Results showed that out of the 301 sites in the study, 8% maintained better than expected site performance, 80% performed as expected, and 11% displayed worse than expected performance. In sites with worse than expected performance rates, patients experienced a higher likelihood of stroke, life-threatening or disabling bleeding, 30-day mortality, and moderate or severe peri-valvular leak.

"Using a novel measure based on ranked 30-day outcomes, we have identified significant hospital-level variation in mortality and major complications after TAVR procedures in the [U.S.]," the authors conclude. "Further study is necessary to determine the impact of these measures on TAVR outcomes and structural, process-related, and technical factors associated with high and low-performing sites."

They add that the novel ranked composite performance measure "is scheduled to be publicly reported beginning in mid-2021 as part of ongoing STS/ACC TVT Registry quality improvement initiatives."

Clinical Topics: Cardiac Surgery, Invasive Cardiovascular Angiography and Intervention, Valvular Heart Disease, Cardiac Surgery and VHD, Interventions and Structural Heart Disease

Keywords: Transcatheter Aortic Valve Replacement, Quality Improvement, Heart Valve Diseases, Registries, Stroke, Acute Kidney Injury, Hospitals, National Cardiovascular Data Registries, STS/ACC TVT Registry


< Back to Listings